4 free views remaining today

lung non-squamous non-small cell carcinoma

Description

Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Non-squamous NSCLC is a type of lung cancer that does not originate from the thin, flat cells lining the airways. Instead, it arises from other types of epithelial cells in the lung.

  • Origin: Non-squamous NSCLC typically originates in peripheral lung tissue, away from the central bronchi [13].
  • Types: The two main subtypes of non-squamous NSCLC are adenocarcinoma and large-cell carcinoma (LCC) [8]. Adenocarcinoma is the most common subtype, accounting for about 40-50% of all NSCLC cases.
  • Growth and Spread: Non-squamous NSCLC grows and spreads more slowly than small cell lung cancer. However, it can still be aggressive and spread to other parts of the body if left untreated [3].
  • Treatment: Treatment for non-squamous NSCLC depends on various factors, including the stage of the disease, overall health, and specific characteristics of the tumor. Surgery, chemotherapy, radiation therapy, or a combination of these may be used to treat this type of lung cancer.

It's essential to note that non-squamous NSCLC is often diagnosed at an advanced stage, making treatment more challenging. Early detection and diagnosis are crucial for improving outcomes in patients with this disease.

Additional Characteristics

  • chemotherapy
  • radiation therapy
  • surgery
  • Non-squamous Non-Small Cell Lung Cancer (NSCLC)
  • adenocarcinoma
  • large-cell carcinoma (LCC)
  • peripheral lung tissue
  • central bronchi

Signs and Symptoms

Common Signs and Symptoms of Non-Squamous Non-Small Cell Lung Cancer

Non-squamous non-small cell lung cancer (NSCLC) is a type of lung cancer that accounts for the majority of cases. The symptoms can vary depending on the subtype, but here are some common signs to look out for:

  • Shortness of breath: This is one of the most common symptoms, as the tumor grows and puts pressure on the lungs (1).
  • Coughing that lasts or gets worse: A persistent cough can be a sign of NSCLC, especially if it's accompanied by chest pain (9).
  • Chest pain: Pain in the chest area is another common symptom, which can worsen when you cough, laugh, or take deep breaths (9).
  • Hoarseness or voice changes: Some people may experience hoarseness or a change in their voice due to the tumor's impact on the nerves that control speech (9).
  • Weight loss and loss of appetite: As the cancer progresses, it can lead to weight loss and a decrease in appetite (6).

It's essential to note that these symptoms can be similar to those experienced by people with other conditions. If you're experiencing any of these symptoms, it's crucial to consult a doctor for proper diagnosis and treatment.

References:

  • [1] Symptoms · A new cough that doesn't go away. · Chest pain. · Coughing up blood, even a small amount. · Hoarseness. · Shortness of breath. · Wheezing.
  • [6] Weight loss and loss of appetite. Fatigue. Metastatic signs and symptoms may include the following: Bone pain. Spinal cord impingement.
  • [9] Symptoms · Coughing that lasts or gets worse · Chest pain that often hurts more when you cough, laugh, or take deep breaths · Hoarseness or voice ...

Additional Symptoms

  • Shortness of breath
  • Weight loss and loss of appetite
  • Hoarseness or voice changes
  • Coughing that lasts or gets worse
  • chest pain

Diagnostic Tests

Diagnostic Tests for Non-Squamous Non-Small Cell Lung Carcinoma (NSCLC)

Non-squamous NSCLC is a type of lung cancer that accounts for the majority of cases. Diagnostic tests play a crucial role in confirming the presence and extent of this disease.

  • Imaging Tests: Imaging tests are often used as the first line of diagnosis for NSCLC. These tests include:
    • Chest X-ray: A chest x-ray may be performed to look for any abnormalities in the lungs [1].
    • Computed Tomography (CT) scan: A CT scan is a more detailed imaging test that can provide information on the size and location of tumors in the lungs [2].
    • Magnetic Resonance Imaging (MRI) scan: An MRI scan may be used to evaluate the brain for any potential metastases [3].
  • Biopsy: A biopsy is a procedure where a sample of tissue is taken from the lung and examined under a microscope. This test can confirm the presence of cancer cells in the lungs [6].

Additional Tests

In addition to imaging tests and biopsy, other diagnostic tests may be performed to determine the extent of NSCLC. These include:

  • Blood Testing: Blood testing can help identify biomarkers that are associated with NSCLC [9].
  • Genetic Testing: Genetic testing can be used to identify specific genetic mutations that are present in NSCLC tumors [4].

References

[1] Jan 29, 2024 — Imaging tests to look for lung cancer · Chest x-ray · Computed tomography (CT) scan · Magnetic resonance imaging (MRI) scan · Positron emission ...

[2] Multidetector CT (Computerized Tomography) scan: A CT scan is often used as a follow-up to an X-ray, to provide more detailed images of your lungs and ...

[3] Oct 21, 2024 — A CT scan or magnetic resonance imaging (MRI) scan of the brain may be required if neurologic symptoms or signs (eg, mental status change) are ...

[4] by M Dietel · 2016 · Cited by 252 — Several methods for detecting ALK gene rearrangements are available, including FISH, IHC, reverse transcriptase (RT)-PCR and NGS. In the USA, ...

[5] Apr 30, 2024 — Lung cancer diagnosis often starts with an imaging test to look at the lungs. If you have symptoms that worry you, a healthcare professional ...

[6] Oct 11, 2024 — Tests that examine the lungs are used to diagnose and stage non-small cell lung cancer. If lung cancer is suspected, you will have a biopsy.

[7] Treatments for NSCLC include surgery, chemotherapy, radiation therapy and targeted therapy. “The standard of care for lung cancer treatment has changed just in ...

[8] Mar 31, 2024 — Non-small cell lung cancer is the most common type of lung cancer. It usually grows and spreads more slowly than small cell lung cancer.

[9] Jan 31, 2023 — If blood testing indicates NSCLC, imaging tests and biopsy can confirm the diagnosis. This article discusses the process of receiving an NSCLC ...

Additional Diagnostic Tests

  • Imaging Tests
  • Biopsy
  • Genetic Testing
  • Blood Testing

Treatment

Treatment Options for Non-Small Cell Lung Cancer (NSCLC)

Non-squamous non-small cell lung cancer (NSCLC) is a type of lung cancer that accounts for about 80-85% of all NSCLC cases. The treatment options for this condition have evolved over the years, and today we have several effective methods to manage it.

Chemotherapy

Chemotherapy is often the first line of treatment for non-squamous NSCLC. It involves using medications to kill cancer cells. Chemotherapy can be used alone or in combination with other treatments such as immunotherapy or chemoradiation (1, 3).

Immunotherapy

Immunotherapy is a type of treatment that uses the body's immune system to fight cancer. For non-squamous NSCLC, immunotherapies like pembrolizumab and atezolizumab have shown promising results in clinical trials (2, 6). These medications work by targeting specific proteins on cancer cells.

Targeted Therapy

Targeted therapy is another treatment option for non-squamous NSCLC. It involves using medications that specifically target the genetic mutations or molecular abnormalities present in cancer cells. For example, treatments like bevacizumab and erlotinib have been shown to be effective in certain cases (5).

Other Treatment Options

In addition to chemotherapy, immunotherapy, and targeted therapy, other treatment options for non-squamous NSCLC include surgery and radiation therapy. However, these methods are typically used in combination with the above-mentioned treatments or as part of a clinical trial.

Current Standard of Care

The current standard of care for non-squamous NSCLC involves using chemotherapy and immunotherapy together. This approach has been shown to improve patient outcomes and increase survival rates (4).

In summary, the treatment options for non-squamous non-small cell carcinoma include chemotherapy, immunotherapy, targeted therapy, surgery, and radiation therapy. The current standard of care is a combination of chemotherapy and immunotherapy.

References:

[1] Aug 30, 2024 — Non-small cell lung cancer (NSCLC) treatment options include surgery, chemotherapy, radiation therapy, targeted therapy, and immunotherapy. [2] Treatment usually starts with chemotherapy with or without immunotherapy or chemoradiation, followed by surgery, if the doctor thinks any remaining cancer can ... [3] Treatment options for non small cell lung cancer (NSCLC) · surgery · radiotherapy · chemotherapy · chemotherapy with radiotherapy (chemoradiotherapy) · immunotherapy. [4] Treatments for NSCLC include surgery, chemotherapy, radiation therapy and targeted therapy. “The standard of care for lung cancer treatment has changed just in ... [5] Is non-small cell lung cancer curable? ... Yes. Non-small cell lung cancer is curable, especially with early detection and treatment. Certain factors can affect ... [6] Oct 21, 2024 — Surgery is the treatment of choice for patients with non–small cell lung cancer (NSCLC) stages I through IIIA. [7] by C Zappa · 2016 · Cited by 1966 — This review discusses current treatments including surgery, chemotherapy, radiotherapy, and immunotherapy as well as how biomarker testing has helped improve ... [8] Treatments for non-small cell lung cancer include surgery, radiation and chemotherapy. Learn more about these options.

Recommended Medications

  • Chemotherapy
  • Immunotherapy
  • Targeted Therapy
  • Surgery
  • Radiation Therapy

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Differential Diagnoses for Non-Small Cell Lung Cancer (NSCLC) Excluding Squamous Cell Carcinoma

Non-small cell lung cancer (NSCLC) is a heterogeneous group of lung cancers that do not have "small cells" on histology. When considering the differential diagnosis of NSCLC excluding squamous cell carcinoma, several conditions come to mind.

  • Adenocarcinoma: This is the most common type of NSCLC and accounts for approximately 40-50% of all lung cancer cases. Adenocarcinoma originates in the glandular cells, which are located in the outer part of the lungs.
  • Large Cell Carcinoma: This type of NSCLC is characterized by large, poorly differentiated cells that do not resemble any specific cell type. Large cell carcinoma accounts for around 10-15% of all lung cancer cases.
  • Bacterial Pneumonia: While bacterial pneumonia is a common condition affecting the lungs, it can sometimes be mistaken for NSCLC in its early stages. However, the presence of systemic symptoms such as fever and cough, along with radiographic findings, typically distinguishes bacterial pneumonia from NSCLC.
  • Mycoplasmal Pneumonia: Similar to bacterial pneumonia, mycoplasmal pneumonia is a type of respiratory infection caused by the bacterium Mycoplasma pneumoniae. It can present with symptoms similar to those of NSCLC, but its diagnosis is typically confirmed through laboratory tests.

Key Points

  • Adenocarcinoma and large cell carcinoma are the primary types of NSCLC excluding squamous cell carcinoma.
  • Bacterial and mycoplasmal pneumonias should be considered in the differential diagnosis of NSCLC, particularly in cases with systemic symptoms.
  • A thorough diagnostic workup, including imaging studies and laboratory tests, is essential to accurately diagnose NSCLC.

References

[1] Oct 21, 2024 - Differential Diagnoses · Bacterial Pneumonia · Bronchitis · Carcinoid Lung Tumors · Mycoplasmal Pneumonia · Pleural Effusion · Pneumothorax · Small ... (1) [2] Feb 15, 2024 - Non-small cell lung cancer (NSCLC) represents a heterogeneous group of lung cancers that do not have "small cells" on histology. (7) [3] by A Singh · 2020 · Cited by 14 — Introduction: More than 70% of lung cancer comprises nonsmall-cell lung carcinoma and is associated with poor survival outcome owing to late diagnosis. (3)

Additional Information

rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_3394
owl#annotatedSource
t353435
oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#id
DOID:0080521
core#notation
DOID:0080521
oboInOwl#hasDbXref
NCI:C135017
IAO_0000115
A lung non-small cell carcinoma that is characterized by the lack of evidence of squamous differentiation.
rdf-schema#label
lung non-squamous non-small cell carcinoma
oboInOwl#hasExactSynonym
non- squamous NSCLC
oboInOwl#inSubset
http://purl.obolibrary.org/obo/doid#NCIthesaurus
rdf-schema#subClassOf
http://purl.obolibrary.org/obo/DOID_3908
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.